Jazz Pharmaceuticals plc
JAZZ
$244.96
-$0.89-0.36%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 940.76M | 29.46M | -356.14M | -368.47M | -404.83M |
| Total Depreciation and Amortization | 717.92M | 712.82M | 696.22M | 685.46M | 672.45M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 50.75M | 872.85M | 996.75M | 1.06B | 1.19B |
| Change in Net Operating Assets | -48.39M | -280.99M | 18.91M | 11.72M | -145.51M |
| Cash from Operations | 1.66B | 1.33B | 1.36B | 1.39B | 1.32B |
| Capital Expenditure | -69.70M | -64.50M | -58.70M | -55.26M | -50.88M |
| Sale of Property, Plant, and Equipment | 28.17M | 28.17M | 28.17M | -- | -- |
| Cash Acquisitions | 0.00 | -858.10M | -858.10M | -858.10M | -858.10M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -180.43M | -323.43M | -621.33M | -417.73M | 119.78M |
| Cash from Investing | -221.96M | -1.22B | -1.51B | -1.33B | -789.20M |
| Total Debt Issued | -- | -- | -- | 0.00 | 980.77M |
| Total Debt Repaid | -1.03B | -31.00M | -781.00M | -781.00M | -1.36B |
| Issuance of Common Stock | 141.52M | 129.32M | 107.92M | 31.93M | 31.21M |
| Repurchase of Common Stock | -118.91M | -236.61M | -200.21M | -202.22M | -350.01M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -5.72M | -5.72M |
| Cash from Financing | -1.01B | -138.29M | -873.29M | -957.00M | -699.75M |
| Foreign Exchange rate Adjustments | -764.00K | 4.44M | 6.54M | 4.21M | 7.08M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 429.92M | -17.58M | -1.02B | -892.08M | -165.94M |